Embecta acquires Owen Mumford
Embecta agreed to acquire Owen Mumford. Reported deal value: £150M. Status: Announced. Sector: medical devices. Target headquarters context: Woodstock, Oxfordshire, United Kingdom.
This page summarizes publicly available information about the transaction as of 2026-03-19. Figures and status may change as filings and press coverage update.
Embecta Corp . , a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited , a privately held, UK‑based innovator and manufacturer of medical devices and drug‑delivery technologies, in a transaction valued at up to £150 million
Deal timeline
This transaction is classified in medical devices with a reported deal value of £150M. Figures and status may change as sources update.